Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcranial Ultrasonic Stimulation in Treatment-resistant Depression : an Open-label Pilot Trial

NCT: NCT06085950 · RECRUITING

NCT IDNCT06085950
StatusRECRUITING
Start Date2023-05-09
Completion2028-06
SponsorCentre Hospitalier St Anne (OTHER)
First posted
Last updated

Brief Summary

The primary objective of this study is to optimize the protocol for the TUS administration in patients with TRD while gaining an initial impression of treatment efficacy.

Frequently Asked Questions

What is Transcranial Ultrasonic Stimulation in Treatment-resistant Depression : an Open-label Pilot Trial?

Transcranial Ultrasonic Stimulation in Treatment-resistant Depression : an Open-label Pilot Trial is a clinical trial registered under NCT06085950. Current status: RECRUITING.

What is the status of NCT06085950?

The current status of NCT06085950 (Transcranial Ultrasonic Stimulation in Treatment-resistant Depression : an Open-label Pilot Trial) is: RECRUITING.

When did Transcranial Ultrasonic Stimulation in Treatment-resistant Depression : an Open-label Pilot Trial start?

Transcranial Ultrasonic Stimulation in Treatment-resistant Depression : an Open-label Pilot Trial started on 2023-05-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑